CS Paper Radar

Optimization of Deep Learning Model for Denoising Dose Profiles in Proton Therapy

Junaid Jawaid, Matteo Spezialetti, Gabriele Libardi, Giovanni Stilo, Filippo Mignosi

eess.IV q-bio.QM ·submitted 2026-09-30 15:22 UTC · v1

Abstract

Proton therapy offers a dosimetric advantage over conventional radiotherapy through the Bragg peak, enabling precise dose delivery to the tumour while sparing surrounding tissue. Monte Carlo (MC) simulation provides the most accurate dose calculation but is computationally expensive for clinical workflows. A promising compromise is to simulate with a reduced number of primary histories and recover a high-quality dose distribution through a deep learning denoising step. In this work, we take a 3D multiscale U-Net from recent literature as a case study and investigate two improvements critical for clinical deployment. First, we replace the standard MSE training objective with a differentiable $γ$-index-based loss, extended to native 3D operation, and demonstrate that directly optimising the clinical evaluation metric yields a mean Gamma Passing Rate of 99.47\% at 2mm/2\% and 95.67\% at 1mm/1\% on the test set, compared to 92.10\% and 71.13\% for MSE. Second, we apply L1-norm structured filter pruning to reduce the model's memory footprint, achieving a 13.3\% parameter reduction with negligible performance loss under partial pruning, and 20\% reduction under full-block pruning after fine-tuning.

Closest papers

Nearest neighbours by meaning across the whole index.

Dose-PlanNet: Physics Based Radiotherapy Dose Prediction with Deep Learning

cs.CV physics.med-phcs.LG ·2026-08-27 ·Ankit Bhattacharjee, Sougata Maity, Santam Chakraborty, Indranil Mallick
code/data similarity 0.75
Abstract · The paper consists of 22 pages, 4 figures, 6 tables. The end-to-end pipeline of Dose-PlanNet will soon be made available on the GitHub repos…

Automating prostate radiotherapy treatment planning is dosimetrically complex, particularly for extreme hypofractionated regimens. In this study, we introduce Dose-PlanNet, a physics-guided 3D deep learning architecture designed to predict dose distributions. This model's performance was evaluated on a cohort of patients treated in a prospective trial where two different dose fractionation regimens were employed. Dose-PlanNet achieved comparable target coverage ($D_{95}$), though statistical analysis revealed a marginal reduction in target homogeneity ($p<0.001$) offset. However the model achieved statistically significant improvements in high-dose organ-at-risk sparing ($p<0.001$). When evaluated against strict Prospective Randomized protocol volumetric constraints, automated plans met prespecified clinical acceptance criteria in $11$ out of $14$ Moderate Hypofraction Arm plans and $9$ out of $12$ Stereotactic Body Radiation Therapy Arm plans. This pipeline demonstrates that physics-informed deep learning can accelerate radiotherapy workflows while safely maintaining the stringent dosimetric quality required for high-precision clinical deployment.

0.36

Learning the Dose Manifold: A Latent Diffusion Framework for Volumetric Dose Prediction in Automated Radiotherapy Treatment Planning

cs.CV ·2026-10-19 ·J. Boyer-Chammard, R. Vauclin, M. C. Biston, P. Maury, M. Gau +5 more
similarity 0.70
Abstract · 27 pages, 7 figures plus graphical abstract

Automated treatment planning (ATP) aims to reduce the unwarranted inter-planner variability of manual planning, while improving treatment quality and efficiency. Most ATP pipelines rely on the prediction of the achievable three-dimensional dose distribution for a given anatomy and the subsequent optimization of machine parameters to reproduce it. Diffusion-based methods are largely slice-wise due to the high dimensionality of radiotherapy data, and assume a one-to-one mapping between anatomy and optimal dose despite the multi-objective nature of treatment planning. They are evaluated on their ability to match reference doses and rarely on their integration in ATP frameworks. We present LaDose, a latent diffusion framework for fully volumetric dose prediction. An autoencoder learned on dose distributions, trained so that perturbed latents decode to plausible doses, compresses dose maps 128-fold and enables 3D diffusion on a single GPU. Prescription values are represented as exact scalar vectors that bypass the image encoder, avoiding resampling and latent compression. Multiscale classifier-free guidance allows for the modulation of clinical trade-offs at inference, without retraining or additional labeled data. On 900 clinically delivered head-and-neck volumetric modulated arc therapy plans from five centers, LaDose reached a median absolute error of 1.18 Gy (1.4--1.8\% of the prescription) and was the only one of six frameworks free of systematic bias with respect to the reference distribution. Guidance scales acted predictably on target coverage and organ-at-risk sparing. Integrated with direct aperture optimization, the pipeline generated plans in 15.2 minutes; in a blinded review, senior clinicians rated 14 of 15 plans acceptable without editing.

0.12

DoseBridge: Denoising Diffusion Bridge Model for Dose Prediction in Lung Intensity-Modulated Proton Therapy

cs.CV ·2026-08-10 ·Zerun Zhang, Xiaoda Cong, Xiangkun Xu, Peter Y. Chen, Xuanfeng Ding
similarity 0.70
Abstract

Most radiotherapy dose-prediction models use only CT images and anatomical structures, although intensity-modulated proton therapy (IMPT) dose also depends strongly on beam geometry and available clinical datasets are often small. We present DoseBridge, a denoising diffusion bridge model that uses the patient CT as a structured bridge endpoint and encodes plan-specific beam geometry in a spatially aligned beam mask. Multiscale fusion combines CT, target, organ-at-risk, and beam-mask representations with 1.95% additional parameters. DoseBridge was retrospectively evaluated on single-institution CT images and treatment plans from 52 patients with advanced-stage lung cancer treated with 60 Gy in 30 fractions; 42 cases were used for training and 10 for testing. Performance was assessed using image-similarity, dose-volume, and Lyman-Kutcher-Burman normal-tissue complication probability (NTCP) metrics and compared with two deep-learning models. On the test cohort, DoseBridge achieved a mean absolute error of 4.170 Gy, peak signal-to-noise ratio of 23.06 dB, and structural similarity index of 0.798, outperforming both comparison models on these metrics. Clinical target volume D95 differed from the reference dose by 0.62 +/- 1.6 Gy; signed organ-at-risk mean-dose differences ranged from -0.32 to 0.24 Gy, and NTCP differences were -0.40 +/- 2.2 and 0.52 +/- 3.4 percentage points for acute esophagitis and radiation pneumonitis, respectively. Changing only the beam mask redirected predicted low-dose entrance regions while preserving the high-dose target region. To our knowledge, DoseBridge is the first denoising diffusion bridge model for radiotherapy dose prediction. These results support its feasibility as a beam-aware planning prior for lung IMPT, pending evaluation in larger external cohorts.

0.04

PyDoseRT Proton: A GPU Pencil-Beam Engine with a Convolutional Residual-Correction Network for Fast Proton Dose Calculation

cs.CV physics.med-ph ·2026-09-01 ·Lukas Zimmermann, Hermann Fuchs, Attila Simkó, Gerd Heilemann
similarity 0.68
Abstract · DoseRAD 2026 report - Team DoseHappens

Architecture category. Hybrid method: a physics-based analytical pencil-beam (PB) dose engine followed by a 3-D convolutional residual-correction network (RepVGG-U-Net). We addressed the DoseRAD2026 proton dose-prediction task with PyDoseRT Proton, a GPU-accelerated engine implemented in PyTorch and augmented by a learned residual toward Monte Carlo (MC) accuracy. A double-Gaussian PB kernel was calibrated to GATE/Geant4 integrated depth doses in water in two stages: a classical per-energy curve fit, then a gradient-based fit of the full 3-D dose through the PyTorch physics engine as it retains a differentiable execution path for gradient-based optimization of dose-dependent objectives. The engine computes each beamlet on a beam's-eye-view (BEV) lattice with variance-preserving Gaussian splitting, an analytic nuclear halo, and a Fermi-Eyges heterogeneity term, then rotates the result into the patient frame. Additionally, a compact residual U-Net predicts an additive correction in BEV space. It is conditioned on voxelwise material-label embeddings, a discrete energy embedding and spot size. The same model was used for all anatomical sites (thoracic and abdominal). It was trained with a patient-space L1 objective emphasizing the scored high-dose region and multi-scale BEV deep supervision. The submitted CT configuration obtained preliminary-test beamlet MAE 0.0066, image-z IDD distance 0.0025, plan MAE 0.0049, 98.30\% gamma pass rate (1\%/1 mm), and DVH error 0.460.

0.25

Coarse-to-Fine Diffusion with Residual Prior for Low-Dose CT Denoising

eess.IV ·2026-09-30 ·Ping Wu, Pengcheng Zheng, Jiahao Zhang, Bohao Chen, Yazhou Ren +1 more
similarity 0.65
Abstract · 10 pages

Low-dose CT (LDCT) reduces radiation exposure but often introduces severe noise and streak artifacts that obscure subtle anatomical structures. Existing diffusion-based denoising methods commonly rely on implicit assumptions about the noise distribution, which may not hold in practical LDCT scenarios and can degrade denoising performance. To address this limitation, we propose a Residual-Guided Diffusion framework that effectively incorporates an explicit difference prior to inform the diffusion process of noise distribution. The difference prior is computed as the residual between the LDCT image and a coarse clean estimate, constraining diffusion sampling to a plausible residual space. We further adopt a coarse-to-fine strategy in which a pre-trained RED-CNN provides the coarse estimate to anchor global anatomy, and the diffusion model refines the remaining details under the prior guidance. For efficiency, we employ accelerated sampling with 20 steps at inference. Experiments on three representative datasets demonstrate that our approach outperforms existing methods in both quantitative and qualitative performance measures.

0.14

BEAM3R: Beam's-eye-view architecture with Mamba-3 for implicit dose reconstruction

cs.CV physics.med-ph ·2026-09-04 ·Chen Cheng, Michael Ferraro, James Grover, David E J Waddington, Emily Hewson
similarity 0.64
Abstract · 14 pages, 5 figures

To enable accurate and rapid photon control point and proton beamlet dose calculation in the DoseRAD2026 challenge, we present BEAM3R, a dose estimation framework operating in beam's-eye-view (BEV). Our core innovation combines a Mamba-3 state-space depth-sequence core with physics-based transport conditioning to model long-range depth transport without expensive 3D convolutions. BEAM3R shares a 2D CNN encoder-decoder architecture for photon and proton dose tasks, processing per-plane BEV slices. Proton beamlets are conditioned on water equivalent thickness and remaining range, encoding the parameters determining Bragg peak position. Photon models use a bidirectional Mamba-3 core to capture dose contributions from materials downstream of the calculation point, while the proton model uses a forward core with learned energy-prefix tokens and a Bragg-peak refinement module. To reduce interpolation artifacts and support high spatial resolution, we introduce axial grid alignment of BEV lattices with CT slices and an implicit super-resolution representation via sub-pixel phase packing, evaluated by a differentiable Triton-accelerated resampler that reconstructs packed cubic B-spline coefficients directly in CT space. For MRI-based tasks, synthetic CTs (sCT) are generated by a patch-based conditional GAN with a SwinUNETR backbone. On the preliminary DoseRAD2026 test set, CT-to-photon and CT-to-proton models achieved 1%/1 mm local gamma pass rates of 96.8% and 96.0%, with stratified plan-level MAEs of 0.0041 and 0.0079. Substituting sCT reduced gamma pass rates to 89.7% for photon and 75.4% proton plan level doses, with stratified plan-level MAEs of 0.0093 and 0.0336. Standardised runtimes were 23.4 s and 18.4 s for CT-to-photon and CT-to-proton prediction, increasing to 39.7 s and 42.8 s for the corresponding MRI-based pipelines.

0.19

Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy Using Temporal Deep Learning on DWI

cs.AI ·2026-08-18 ·Pablo García Marcos, Md. Tarequl Islam, Paula Puerta González, Guillermo Lorenzo, Héctor Gómez +3 more
similarity 0.62
Abstract

Early identification of non-responders to neoadjuvant chemotherapy (NACT) is crucial for timely treatment adaptation in breast cancer. However, many existing predictive models rely on multiparametric magnetic resonance imaging (MRI), late treatment time points, or extensive clinical data, which limits their applicability. This study proposes a deep learning framework for early prediction of pathological complete response (pCR) using only diffusion-weighted MRI (DW-MRI) acquired at baseline and after the first NACT cycle. This framework feeds cropped tumor-centered patches to an EfficientNet-based temporal model that directly learns tumor shape and local tissue characteristics without explicit radiomic feature engineering. The model, trained with 10-fold cross-validation, achieved an area under the receiver operating characteristic curve (AUC) of 0.90 for pCR prediction after one cycle, providing actionable information after a single treatment cycle while avoiding gadolinium administration and reducing dependence on heterogeneous clinical data. By focusing on the baseline-to-first-cycle window instead of later stages, the approach supports earlier escalation or de-escalation of NACT, and its exclusive reliance on DW-MRI facilitates protocol standardization, multi-centre deployment and privacy-preserving data sharing. These results demonstrate that DW-MRI-based deep learning on tumor-centered patches constitutes a minimally invasive, clinically deployable strategy for early pCR prediction, with direct implications for personalized treatment adaptation in neoadjuvant breast cancer therapy.

0.21

Prior-Guided Physics-Informed Deep Learning for Fast 4D MRI Reconstruction

cs.CV physics.med-ph ·2026-11-01 ·Mojtaba Safari, Parag J. Parikh, Shansong Wang, Mingzhe Hu, Philip Connell +4 more
similarity 0.61
Abstract

Background and purpose: We propose PGPI4MR (prior-guided, physics-informed 4D MRI reconstruction), a deep learning method that leverages information from other respiratory phases or a setup scan, the first 30 s of the same scan, to improve 4D MRI reconstruction without extra scan time. Materials and methods: PGPI4MR is an unrolled network that reconstructs 16 respiratory phases from 60, 30, or 15 s of data, and single 3D volumes, each from 0.29-0.49 s of data, using a setup-scan image. The networks were trained once, on other volunteers, and were not retrained for new volunteers. We evaluated PGPI4MR on measured k-space from three datasets: free-breathing MR-linac (1.5T) and abdominal (3T) scans, and thigh scans with cuff compression (1.5T). All methods, including comparative models, received identical samples and were scored similarly. Results: In vivo, PGPI4MR had the lowest held-out error for 4D MRI at every scan time, and its 16 phases were ready a median of 7.5-13 s after the scan on the 2 GPUs tested. Coupling the 16 respiratory phases reduced the error at 60 s by 9.1% compared with reconstructing each phase alone. For sub-second MRI, the error at 0.49 s was 15.5% lower than that of the best comparison method, classical reconstruction toward the same prior, and on the faster GPU, every 0.29 s window was acquired and reconstructed within 0.5 s. Without retraining, PGPI4MR matched the best methods on the 3T abdominal scans but not on the thigh scans; after retraining on thigh data, it reduced the held-out error by 6.6% relative to the best comparison method. Conclusion: Prior information allowed PGPI4MR to reconstruct 4D and sub-second MRI more accurately than compressed sensing and a published 4D network, within seconds and without extra scan time. This could support 4D MRI for treatment planning and 3D motion monitoring during MR-guided radiotherapy.

0.21